Cite
HARVARD Citation
Chen, C. et al. (2020). An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines. Leukemia & lymphoma. 61 (8), pp. 1860-1868. [Online].